company background image
6929 logo

OrbusNeich Medical Group Holdings SEHK:6929 Stock Report

Last Price

HK$4.39

Market Cap

HK$3.6b

7D

-2.2%

1Y

-55.2%

Updated

22 Jun, 2024

Data

Company Financials +

OrbusNeich Medical Group Holdings Limited

SEHK:6929 Stock Report

Market Cap: HK$3.6b

6929 Stock Overview

An investment holding company, researches, develops, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States.

6929 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance4/6
Financial Health5/6
Dividends2/6

OrbusNeich Medical Group Holdings Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OrbusNeich Medical Group Holdings
Historical stock prices
Current Share PriceHK$4.39
52 Week HighHK$10.20
52 Week LowHK$3.01
Beta0
11 Month Change0%
3 Month Change39.37%
1 Year Change-55.25%
33 Year Changen/a
5 Year Changen/a
Change since IPO-52.02%

Recent News & Updates

Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

May 28
Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

May 06
Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Apr 25
OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Recent updates

Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

May 28
Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

May 06
Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Apr 25
OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Mar 13
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

Feb 04
Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Oct 20
A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

Jun 01
Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

Shareholder Returns

6929HK Medical EquipmentHK Market
7D-2.2%-5.6%0.6%
1Y-55.2%-43.1%2.4%

Return vs Industry: 6929 underperformed the Hong Kong Medical Equipment industry which returned -43.1% over the past year.

Return vs Market: 6929 underperformed the Hong Kong Market which returned 2.4% over the past year.

Price Volatility

Is 6929's price volatile compared to industry and market?
6929 volatility
6929 Average Weekly Movement7.2%
Medical Equipment Industry Average Movement7.2%
Market Average Movement7.1%
10% most volatile stocks in HK Market15.1%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 6929's share price has been volatile over the past 3 months.

Volatility Over Time: 6929's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20011,249David Chienorbusneich.com

OrbusNeich Medical Group Holdings Limited, an investment holding company, researches, develops, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as sirolimus-eluting coronary stents, peripheral self-expandable stents, and paclitaxel-coated PTCA and PTA balloons. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures.

OrbusNeich Medical Group Holdings Limited Fundamentals Summary

How do OrbusNeich Medical Group Holdings's earnings and revenue compare to its market cap?
6929 fundamental statistics
Market capHK$3.63b
Earnings (TTM)HK$351.81m
Revenue (TTM)HK$1.20b

10.3x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6929 income statement (TTM)
RevenueUS$153.87m
Cost of RevenueUS$47.37m
Gross ProfitUS$106.50m
Other ExpensesUS$61.43m
EarningsUS$45.07m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.054
Gross Margin69.22%
Net Profit Margin29.29%
Debt/Equity Ratio1.1%

How did 6929 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

24%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.